Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds
TipRanksMar 23 00:45
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Milestone Pharmaceuticals (MIST)
TipRanksMar 23 00:40
Buy Rating Affirmed for Plus Therapeutics Amid Strong Financials and Promising Clinical Trials
TipRanksMar 7 23:35
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), HUTCHMED (HCM) and Plus Therapeutics (PSTV)
TipRanksNov 29, 2023 05:40
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Ambrx Biopharma (AMAM) and Marinus (MRNS)
TipRanksNov 21, 2023 19:20
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Beyond Air (XAIR) and Ovid Therapeutics (OVID)
TipRanksNov 4, 2023 02:50
Analysts Conflicted on These Healthcare Names: Geron (GERN), Silk Road Medical (SILK) and Plus Therapeutics (PSTV)
TipRanksNov 3, 2023 00:50
Promising Clinical Developments Drive Buy Rating for Plus Therapeutics: Analysis of Recent Trials and Future Prospects
TipRanksOct 12, 2023 01:45
JonesTrading Sticks to Its Buy Rating for Plus Therapeutics (PSTV)
TipRanksSep 12, 2023 00:05
Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Plus Therapeutics (PSTV)
TipRanksAug 17, 2023 00:00
HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target
BenzingaAug 15, 2023 19:05
Plus Therapeutics Analyst Ratings
BenzingaAug 15, 2023 19:01
H.C. Wainwright Keeps Their Buy Rating on Plus Therapeutics (PSTV)
TipRanksAug 14, 2023 20:25
HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target
BenzingaAug 14, 2023 18:35
Plus Therapeutics Analyst Ratings
BenzingaAug 14, 2023 18:34
JonesTrading Keeps Their Buy Rating on Plus Therapeutics (PSTV)
TipRanksJul 5, 2023 21:05
HC Wainwright Adjusts Price Target on Plus Therapeutics to $8 From $3.50, Maintains Buy Rating
MT NewswiresJun 30, 2023 20:30
Maxim Adjusts Price Target on Plus Therapeutics to $12 From $30, Maintains Buy Rating
MT NewswiresMay 3, 2023 23:38
Maxim Group Maintains Buy on Plus Therapeutics, Lowers Price Target to $12
BenzingaMay 3, 2023 22:10
Analysts Are Bullish on Top Healthcare Stocks: Plus Therapeutics (PSTV), Biomea Fusion (BMEA)
TipRanksMay 1, 2023 22:35
No Data
No Data